Delivery Order SPE2DB22D3016-SPE2DB25FAVP3

Award Date 5/5/25
Potential Completion Date 5/27/25
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,679.17 firm fixed-price delivery order is for the supply of the prescription drug XALKORI 250 MG CAPSULE 60S. The contract has an ultimate completion date of May 19, 2023 and was awarded on April 28, 2023. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $14,356.89 and is for the supply of XALKORI 250 MG CAPSULE 60S, a prescription medication. The contract is a Firm Fixed Price type and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $12,865.21 firm-fixed-price contract is for the supply of XALKORI 200 MG CAPSULE 60S, a pharmaceutical product, to support federal healthcare programs. The contract does not have a set-aside designation and has an ultimate completion date of September 24, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $14,356.89, is a Delivery Order with a Firm Fixed Price pricing type and a completion date of February 12, 2025. The award is for the supply of XALKORI 250 MG CAPSULE 60S, a pharmaceutical product, and does not have a set-aside designation. Amerisourcebergen holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for the supply of 4,565,470 units of the prescription drug XALKORI 250 MG CAPSULE 60S, with a ceiling value of $12,877.79. The contract has an ultimate completion date of September 6, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several indefinite delivery contracts (IDCs) with the DLA and other federal agencies for the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a for-profit global pharmaceutical distribution company. The $12,865.21 firm fixed price order is for XALKORI 200 MG CAPSULE 60S, a pharmaceutical product, with a performance period ending on March 25, 2024. AmerisourceBergen Drug Corp serves as the prime contractor and holds an indefinite delivery contract (IDC) with DLA Troop Support Medical to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XELJANZ XR 11 MG TABLET, a specialty pharmaceutical product, and has a ceiling value of $3,472.13. The contract is a firm fixed price agreement and has an ultimate completion date of July 11, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency's (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract has a total ceiling value of $7,721.44 and is for the supply of the prescription drug XELJANZ XR 11 MG TABLET with an ultimate completion date of May 15, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $29,823.95, is for the delivery of the specialty medication Xeljanz XR 11 mg tablets. The contract is a firm-fixed-price Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of...
This is a $7,837.41 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of XELJANZ XR 11 MG TABLET UU 30S, a prescription medication. The contract has an ultimate completion date of May 28, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FAVP3
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $14,419.30, is for the supply of 60-count capsules of the prescription medication Xalkori 200 mg. The contract has a period of performance through May 27, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle for military and government healthcare programs through December 2026. The contract is not set aside for any specific business category.

Generated 8/4/25, 9:54 AM